Skip to Content
Merck
CN
  • Temporal endogenous gene expression profiles in response to lipid-mediated transfection.

Temporal endogenous gene expression profiles in response to lipid-mediated transfection.

The journal of gene medicine (2015-02-11)
Timothy M Martin, Sarah A Plautz, Angela K Pannier
ABSTRACT

Design of efficient nonviral gene delivery systems is limited as a result of the rudimentary understanding of the specific molecules and processes that facilitate DNA transfer. Lipoplexes formed with Lipofectamine 2000 (LF2000) and plasmid-encoding green fluorescent protein (GFP) were delivered to the HEK 293T cell line. After treating cells with lipoplexes, HG-U133 Affymetrix microarrays were used to identify endogenous genes differentially expressed between treated and untreated cells (2 h exposure) or between flow-separated transfected cells (GFP+) and treated, untransfected cells (GFP-) at 8, 16 and 24 h after lipoplex treatment. Cell priming studies were conducted using pharmacologic agents to alter endogenous levels of the identified differentially expressed genes to determine effect on transfection levels. Relative to untreated cells 2 h after lipoplex treatment, only downregulated genes were identified ≥ 30-fold: ALMS1, ITGB1, FCGR3A, DOCK10 and ZDDHC13. Subsequently, relative to GFP- cells, the GFP+ cell population showed at least a five-fold upregulation of RAP1A and PACSIN3 (8 h) or HSPA6 and RAP1A (16 and 24 h). Pharmacologic studies altering endogenous levels for ALMS1, FCGR3A, and DOCK10 (involved in filopodia protrusions), ITGB1 (integrin signaling), ZDDHC13 (membrane trafficking) and PACSIN3 (proteolytic shedding of membrane receptors) were able to increase or decrease transgene production. RAP1A, PACSIN3 and HSPA6 may help lipoplex-treated cells overcome a transcriptional shutdown due to treatment with lipoplexes and provide new targets for investigating molecular mechanisms of transfection or for enhancing transfection through cell priming or engineering of the nonviral gene delivery system.

MATERIALS
Product Number
Brand
Product Description

Valsartan, European Pharmacopoeia (EP) Reference Standard
USP
Valsartan, United States Pharmacopeia (USP) Reference Standard
Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Water, tested according to Ph. Eur.
Sigma-Aldrich
Water, for cell biology, sterile ultrafiltered
Sigma-Aldrich
Water, for molecular biology, sterile filtered
Supelco
Water, for HPCE, for luminescence, suitable for UV/Vis spectroscopy
Sigma-Aldrich
Trypan Blue, Dye content 60 %, ≥80% (HPLC)
Sigma-Aldrich
1,10-Phenanthroline, ≥99%
Sigma-Aldrich
Sodium pyruvate, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Water, PCR Reagent
Sigma-Aldrich
Water, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
E-Toxate Water, endotoxin, free
Sigma-Aldrich
Water, for embryo transfer, sterile-filtered, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Trypan Blue, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)
Sigma-Aldrich
Sodium pyruvate, Hybri-Max, powder, suitable for hybridoma
Sigma-Aldrich
Sodium pyruvate, BioXtra, ≥99%
Sigma-Aldrich
Sodium pyruvate, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
Hydralazine hydrochloride
Sigma-Aldrich
Water, Nuclease-Free Water, for Molecular Biology
Sigma-Aldrich
Sodium pyruvate, ReagentPlus®, ≥99%
Supelco
Water, for TOC analysis
Sigma-Aldrich
Water, BioPerformance Certified
Supelco
Density Standard 998 kg/m3, H&D Fitzgerald Ltd. Quality
Supelco
Water, for ultratrace analysis, ACS reagent
Sigma-Aldrich
Valsartan, ≥98% (HPLC)
Supelco
Water, suitable for ion chromatography
Sigma-Aldrich
Water, HPLC Plus
Sigma-Aldrich
Water, suitable for HPLC